“…Moreover, this variant was also found to be associated with the risk and survival of cancer, such as epithelial ovarian cancer [32], colon cancer [33,34], non-small cell lung cancer [35], oral cavity cancer [36], and neuroblastoma [16]. LIN28B protein was found to be unregulated in colon tumours, and the overexpression correlated with reduced patient survival and increased probability of tumour recurrence [34,37]; besides, LIN28B can promote migration, invasion, and malignant transformation of cells [38]. Furthermore, studies also found that the overexpression of LIN28B was associated with poor prognosis in head and neck cancer [39], oral squamous cell carcinoma patients [40,41], gastric cancer [42], breast cancer [43], ovarian cancer [44], and neuroblastoma [16,45,46].…”